Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Wai Chun Bio-Technology Ltd. ( (HK:0660) ) has shared an announcement.
Wai Chun Bio-Technology Ltd. has announced plans to amend its Memorandum and Articles of Association to align with new Hong Kong Stock Exchange rules mandating electronic dissemination of corporate communications starting December 31, 2023. These changes are subject to shareholder approval at the upcoming annual general meeting on March 19, 2025, signifying the company’s commitment to compliance and modernization in its operational practices.
More about Wai Chun Bio-Technology Ltd.
Wai Chun Bio-Technology Ltd. operates in the biotechnology industry and is incorporated in the Cayman Islands. The company is listed on the Hong Kong Stock Exchange under stock code 660.
YTD Price Performance: 81.43%
Average Trading Volume: 197,905
Technical Sentiment Consensus Rating: Sell
Current Market Cap: HK$21.78M
For detailed information about 0660 stock, go to TipRanks’ Stock Analysis page.